Nelson Dusetti: Our European project on pancreatic cancer
Nelson Dusetti, Research Director at INSERM, shared a post on LinkedIn about a recent article by INSERM:
“It is an honor for the CRCM – Centre de Recherche en Cancérologie de Marseille (Cancer Research Center of Marseille) and our research team to be highlighted in this article dedicated to our European project on pancreatic cancer.
This recognition underscores the collective efforts of our center and our partners to better understand and treat this complex disease.
We extend our warmest thanks to the INSERM communication team for their support and dedication to showcasing the scientific advances achieved at the CRCM and through European collaborations.”
“A European project to better understand and treat pancreatic cancer”
More More posts featuring Nelson Dusetti.
Nelson Dusetti is the Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023